cerrar
Tagged with GI

Kevin Houdenaert – General Manager, Recordati Benelux…
Kevin Houdenaert, general manager for Benelux and the Nordics at Italian rare disease, specialty and primary care specialist Recordati, gives an…

The Long Read: Belgium – The Multifaceted
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical powerhouses of Germany and France,…

Pharma Faces: Sonja Willems, Janssen Benelux
Belgium is a vitally important country for Johnson & Johnson's pharmaceutical arm, Janssen, globally. In addition to their R&D centre and a…

In Profile: Stéphane De Wit, A Pioneer in HIV Research
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in Brussels since 1983. Initially planning…

Hospital Reform in Belgium: A Guarantee of Better Care?
Belgium’s healthcare system was ranked fourth in Europe in 2019, outperforming its peers across a number of metrics including a relatively high…

Maintaining Open Innovation in Our ‘New Normal’ Through…
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park explores new ways of virtual collaboration that make our lives easier while…

Carl Laurent – Managing Director, Siemens Healthineers…
Carl Laurent, managing director and CEO of Siemens Healthineers BeLux, sits down with PharmaBoardroom to explain Siemens Healthineers’ footprint and…

Axel De Muyt – General Manager & VP, Novo Nordisk…
Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the pharma industry, how he has been able…

The End of “Digital” as a Story of Value
John G. Singer examines why technological solutions are not a quick fix to overcoming the COVID-19 crisis and how a systems shift is crucial to…

Serge Kemps – CEO, Nipro Medical Europe
Serge Kemps, CEO of Nipro Medical Europe, sits down with PharmaBoardroom to shed light on Nipro’s unique corporate culture based on the Japanese…

Launching Zolgensma® in Belgium: Lessons Learned
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy Zolgensma® for the ultra-rare…

GSK: Senior VP for Vaccines R&D on COVID-19 Collaboration
GSK, the world’s largest manufacturer of vaccines, has pursued a different strategy to that of its contemporaries in the effort to develop a safe,…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here